Reference health
The dual role of inflammation and tertiary lymphoid structures in tumor progression and immunity: a literature review and our experience
1 of 34 checkable references need attention · checked 2026-07-24
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
does not resolve to a known work10.1146/annurev.immunol.10.1.561
The 33 checked references that resolve
resolves10.3390/cancers17091547
Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches
resolves10.3389/fimmu.2024.1413067
Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy
resolves10.3389/fimmu.2016.00477
Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation
resolves10.1007/s00018-022-04388-x
Role of tertiary lymphoid organs in the regulation of immune responses in the periphery
resolves10.4049/jimmunol.1203318
Pulmonary Expression of Oncostatin M (OSM) Promotes Inducible BALT Formation Independently of IL-6, Despite a Role for IL-6 in OSM-Driven Pulmonary Inflammation
resolves10.1186/s12967-025-06510-6
Tertiary lymphoid structures in gliomas: impact on tumour immunity and progression
resolves10.18632/oncotarget.23208
Inflammatory responses and inflammation-associated diseases in organs
resolves10.1186/s12943-024-02064-1
Decoding the spatiotemporal heterogeneity of tumor-associated macrophages
resolves10.3389/fimmu.2017.01830
Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?
resolves10.1016/j.canlet.2025.217491
Tertiary lymphoid structures as a biomarker in immunotherapy and beyond: Advancing towards clinical application
resolves10.3389/fimmu.2015.00067
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity
resolves10.4049/jimmunol.1901059
Molecular Drivers of Lymphocyte Organization in Vertebrate Mucosal Surfaces: Revisiting the TNF Superfamily Hypothesis
resolves10.1016/S0002-9440(10)64981-4
Lymphoid Tissue Homing Chemokines Are Expressed in Chronic Inflammation
resolves10.1016/j.smim.2023.101796
Harnessing the power of oncolytic virotherapy and tertiary lymphoid structures to amplify antitumor immune responses in cancer patients
resolves10.3389/fimmu.2016.00401
Understanding Immune Cells in Tertiary Lymphoid Organ Development: It Is All Starting to Come Together
resolves10.1038/s41392-024-02050-5
Tissue-resident immune cells: from defining characteristics to roles in diseases
resolves10.4049/jimmunol.169.1.424
Differing Activities of Homeostatic Chemokines CCL19, CCL21, and CXCL12 in Lymphocyte and Dendritic Cell Recruitment and Lymphoid Neogenesis
resolves10.1038/s41423-020-0457-0
Tertiary lymphoid structures in cancer – considerations for patient prognosis
resolves10.3390/cancers16020396
The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review
resolves10.3390/cancers6020969
Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers
resolves10.1038/ni.2053
The development of inducible bronchus-associated lymphoid tissue depends on IL-17
resolves10.1038/s41698-025-00891-z
Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma
resolves10.1016/j.ejca.2025.115572
Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy
resolves10.1186/s12943-024-01980-6
Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application
resolves10.1038/s41392-024-01947-5
Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances
The 2 references without a DOI — listed, not checked
no DOI — not checkedGulinac M, Dikov D, Lichev S, Velikova T (2020) Current concept for tertiary lymphoid structures in urothelial carcinoma of the bladder: a literature review and our experience. American Journal of Clinical and Experimental Immunology 9(5): 64–72.
no DOI — not checkedPahwa R, Goyal A, Jialal I (2025) Chronic Inflammation. StatPearls. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK493173/
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-24 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.3897/pharmacia.73.e168166"><img src="https://citestamp.com/citestamped/10.3897/pharmacia.73.e168166/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.3897/pharmacia.73.e168166)